Continue Shopping Home Products Self-Injection Platforms SmartDose® Drug Delivery Platform SmartDose® 3.5 Injector SmartDose® 3.5 Injector Leading the way with integrated containment and delivery solutions The first combination product that incorporates the SmartDose® 3.5 Injector has been approved by the U.S. Food and Drug Administration (FDA). The SmartDose injector offers a wearable, subcutaneous injector with an integrated drug delivery system that incorporates human factors and usability testing to deliver a truly patient-centric approach to self-administration. Request More Information Proud to support our partners with our SmartDose® technology: Since 2010, West has invested in development of our SmartDose® technology scaling it to meet various application and delivery volume needs. Patient-Centric Wearable Injector Flexible Technology Technical Specifications Downloadable Resources Related Products Patient-Centric Wearable Injector User loaded, subcutaneous self-administration Ability to deliver high volume and high viscosity drug products Easy to use, intuitive design Visual, tactile and audible feedback to boost user confidence Training solutions available for a seamless onboarding experience Flexible Technology Address a variety of delivery times through adaptable, pre-programmable technology Multiple published studies* indicate lower pain with customizable delivery rates Regulatory, Quality and Human Factors expertise to support your development *Dias, C., Abosaleem, B., Crispino, C., Gao, B. & Shaywitz, A. (2015). Tolerability of High-Volume Subcutaneous Injections of a Viscous Placebo Buffer: A Randomized, Crossover Study in Healthy Subjects. AAPS PharmSciTech. DOI: 10.1208/s12249-015-0288-y Technical Specifications Downloadable Resources SmartDose 3.5 Injector Information Sheet SmartDose 10 Injector Information Sheet SmartDose Platform Market Activity West's Fill-Finish Capabilities West & Swissfillon Partnership Information Sheet Fill-Finish Information Sheet Related Products Integrated Solutions SmartDose® 10 Injector SelfDose™ Patient-Controlled Injector SmartDose® is a registered trademark of West Pharma. Services IL, Ltd., a subsidiary of West Pharmaceutical Services, Inc. Flurotec® is a registered trademark of Daikyo Seiko, Ltd. SelfDose™ is a trademark of West Pharmaceutical Services, Inc. The logos above are the property of their respective owners and are used with permission. Related Blogs PRODUCTS Vial Containment Solutions Prefillable Systems Self-Injection Platforms Cartridge Systems And Components Reconstitution & Transfer Systems Specialty Components Quality Enhancements SERVICES Analytical Services West Contract Manufacturing Integrated Solutions CHALLENGES Reducing Time To Market Reducing Total Cost Of Ownership Packaging Solutions For Sensitive Molecules Single Source Solution SUPPORT Coronavirus Update Knowledge Center Get A Product Recommendation Fill-Finish Support Services Quality Support Regulatory Support Contact Us Recent Press Releases West To Participate In Upcoming Investor Conferences West Announces Third-Quarter 2021 Results And Declares Fourth-Quarter 2021 Dividend West'S NovaGuard® SA Pro Safety System Recognized For Best Technologies Innovation At INTERPHEX All Press Releases Email Subscriptions Partners Legal Notices Imprint UK Tax Strategy Terms & Conditions Privacy Policy DeltaCube Terms Of Service ©2021 West Pharmaceutical Services, Inc.®All Rights Reserved. Feedback